-
Gallant Advances Canine Osteoarthritis IV-Delivered Stem Cell Therapy with Promising Pilot Data and Expanded FDA Conditional Approval Pathway Eligibility
Recent Milestones Aim to Bring a New Category of Care to One of Veterinary Medicine’s Largest Unmet Needs Gallant granted eligibility for expanded conditional approval by FDA-CVM for canine osteoarthritis (OA) stem cell therapy; targeting conditional approval in 2028. Randomized, blinded, placebo-controlled pilot study shows statistically significant improvement in Gallant’s uterine-derived mesenchymal stromal cell (UMSC)
-
Coral Gables Hospital CEO Natalie Rodriguez Emerges as a Leading Voice in Healthcare and Community Leadership
CORAL GABLES, Fla., May 6, 2026 /PRNewswire/ — Coral Gables Hospital highlights the impactful start of Chief Executive Officer Natalie Rodriguez, whose leadership is already resonating across the City Beautiful through visibility, engagement, and a clear vision for the future. Coral Gables Hospital’s Earth Day Celebration, themed “Growing Today for a Greener Tomorrow.” Fifth Annual
-
Momentum Life Sciences Announces 2026 Impact Award Winners
Annual Recognition Shines the Spotlight on Three Outstanding Team Members During National Nurses Week INDIANAPOLIS, May 6, 2026 /PRNewswire/ — During this year’s National Nurses Week celebration, Momentum Life Sciences presented its annual Impact Awards to three outstanding individuals: Tonja Guthrie, Virtual Nurse Educator, Aimee Johnson, Case Manager and Shari Mott, Field Nurse Educator. Momentum Life
-
Molecular Instruments & Empire Genomics Launch NISH Powered by HCR™ Pro: The Largest Ready-to-Use, Fully Automated ISH Library, Exclusively Available Worldwide on NeoPATH Pro
LOS ANGELES and BUFFALO, N.Y., May 5, 2026 /PRNewswire/ — Empire Genomics, a Biocare Medical company, and Molecular Instruments® (MI), founded by the inventor of HCR™ technology, today launched NISH (Neo in situ hybridization) — the largest ready-to-use, fully automated ISH library for research – exclusively available worldwide on the NeoPATH Pro automated staining platform.
-
RTI International and Navidence Partner to Solve a Persistent Gap in Real-World Evidence: Standardizing How Diseases, Treatments and Outcomes Are Defined
Strategic investment brings together RTI’s scientific leadership and Navidence AI-native platform to improve research quality, reproducibility, and patient outcomes across the life sciences RESEARCH TRIANGLE PARK, N.C., May 5, 2026 /PRNewswire/ — Independent scientific research institute RTI International today announced a partnership and strategic equity investment in Navidence, a technology and knowledge content company focused on defining
-
Free Asbestos Screening Goes Mobile: CARDs Outreach and Education Available Across the Nation
LIBBY, Mont., May 5, 2026 /PRNewswire/ — The Center for Asbestos-Related Disease (CARD), a nationally recognized leader in asbestos-related education, outreach, and research, is expanding its efforts to reach communities across the country while continuing to serve those most affected by exposure. Drawing on decades of experience, CARD works with public health leaders, academic institutions,
-
Lunakai Emphasizes Clean Vitamins Focus Heading Into Summer
The Brand’s Well-Established Approach to Supplementation Continues to Shine in 2026 FORT LAUDERDALE, Fla., May 5, 2026 /PRNewswire/ — Vitamin and supplement trends continue to resemble 2025 heading into the new year. However, there are a few nuances consumers are seeking as they refine their expectations around holistic living. Lunakai is a wellness label that continues
-
Mel-Mont Medical Recognized at ASCCP with the Best Innovative Technology in HPV mRNA-Based Cervical Cancer Triage
Recognition highlights growing momentum toward more accessible, patient-centered screening and type specific risk assessment after a positive HPV result DORAL, Fla., May 5, 2026 /PRNewswire/ — Mel-Mont Medical, a women’s health diagnostics company advancing accessible cervical cancer screening through HPV-positive patient risk assessment, announced today that it was recognized at the 2026 American Society for Colposcopy and
-
Former U.S. Surgeon General Dr. Jerome Adams Joins WellGenie™ Advisory Board
Public health leader brings state and federal experience to a benefits platform purpose-built around preventive care and equitable access HOUSTON, May 4, 2026 /PRNewswire/ — WellGenie™, the integrated employee health benefits platform behind the emerging Welltegriti category, today announced that Dr. Jerome Adams, the 20th Surgeon General of the United States, has joined the company’s
-
SuperTruth Launches Sean’s Friends Donor Advised Fund and Commits That the Company Will Never Profit From Children
Founding tenet, not future arm. First grant directs proceeds to Children’s Hospital of Philadelphia; all future SuperTruth revenue from pediatric work to flow back into the fund. PHILADELPHIA, May 1, 2026 /PRNewswire/ — SuperTruth, the healthcare data verification company building the proof layer for AI in medicine, today launched Sean’s Friends, a donor-advised fund administered through
